Market Cap (In USD)
222.35 Million
Revenue (In USD)
-
Net Income (In USD)
-29.15 Million
Avg. Volume
33.51 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.75-3.4
- PE
- -
- EPS
- -
- Beta Value
- 0.771
- ISIN
- IL0011839383
- CUSIP
- M0740A108
- CIK
- 1871321
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Uzi Sofer
- Employee Count
- -
- Website
- https://www.alphatau.com
- Ipo Date
- 2021-03-08
- Details
- Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.
More Stocks
-
VAHN
-
HINKFHeineken N.V.
HINKF
-
0LTG
-
IPRINGLTDIP Rings Limited
IPRINGLTD
-
DOLHF
-
FFTTFFatfish Group Limited
FFTTF
-
000048
-
CMRZFCommerce Resources Corp.
CMRZF